Comparison of the real-world safety of two different long-acting methylphenidate formulations (Medikinet® MR and Concerta®) – a Danish nationwide register-based cohort study Cover

.blurhash-client-img { display: none !important; }

Comparison of the real-world safety of two different long-acting methylphenidate formulations (Medikinet® MR and Concerta®) – a Danish nationwide register-based cohort study

Scandinavian Journal of Child and Adolescent Psychiatry and Psychology

Volume 12 (2024): Issue 1 (January 2024)

By: Jakob Ørnberg, Anke Mayer, Oliver Dangel and Richard Ammer

Open Access

|Nov 2024

Authors

Jakob Ørnberg

Neuropsykiatrisk Klinik, Privat Hospitalet Mølholm, Højbjerg, Denmark

Anke Mayer

MEDICE Arzneimittel Pütter GmbH & Co. KG, Iserlohn, Germany

Oliver Dangel

MEDICE Arzneimittel Pütter GmbH & Co. KG, Iserlohn, Germany

Richard Ammer

richard.ammer@ukmuenster.de

MEDICE Arzneimittel Pütter GmbH & Co. KG, Iserlohn, Germany

Department of Nephrology, University Hospital Münster, Münster, Germany

DOI: https://doi.org/10.2478/sjcapp-2024-0009 | Journal eISSN: 2245-8875

Journal RSS Feed

Language: English

Page range: 84 - 91

Published on: Nov 16, 2024

Published by: Psychiatric Research Unit

In partnership with: Paradigm Publishing Services

Publication frequency: 1 issue per year

Keywords:

Methylphenidate,

real-world safety,

adverse events,

attention-deficit hyperactivity disorder,

Related subjects:

Basic medical science,

Basic medical science, other

© 2024 Jakob Ørnberg, Anke Mayer, Oliver Dangel, Richard Ammer, published by Psychiatric Research Unit
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 12 (2024): Issue 1 (January 2024)Next article